Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05868213 · ClinicalTrials.gov registry record
Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 1
A clinical trial, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- 96
- Enrollment target
NCT05868213: Completed study, sponsored by University of Colorado, Boulder.
NCT05868213 is a clinical trial that has completed, run by University of Colorado, Boulder. The registered enrollment target is 96 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05868213 has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- 96 participants
- Enrollment target
Study Summary
This study investigates the impact of ∆9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on recognition memory in healthy, regular cannabis users. Participants complete the same recognition memory task after self-administering one of three different strains of cannabis flower one day and while not intoxicated another day. Event-related potentials (ERPs) are measured via electroencephalogram (EEG) during the recognition memory task. Blood is collected to quantify THC and CBD exposure. Participants also complete self-report measures of medical history, sleep quality, subjective cognitive function, physical activity, psychological functioning, substance use, and acute drug effects.
Primary Outcome
Electroencephalography is used to quantify FN400 and parietal ERP effects.
Interventions
- DRUG Cannabis (smoked flower)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2022-08-17 |
| Est. Completion | 2024-12-15 |
What the finished NCT05868213 record still lists
NCT05868213 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 96 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Cannabis (smoked flower) is the first listed.
NCT05868213 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05868213 about?
NCT05868213 is a clinical study titled "Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 1". This study investigates the impact of ∆9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on recognition memory in healthy, regular cannabis users. Participants complete the same recognition memory task after self-administering one of three different strains of cannabis flower one day and while not ...
What is the current status of trial NCT05868213?
This trial is currently completed. The enrollment target is 96 participants. The study started on 2022-08-17. Estimated completion is 2024-12-15.
What interventions are being tested in trial NCT05868213?
The interventions under investigation include: Cannabis (smoked flower) (DRUG).
Who is sponsoring clinical trial NCT05868213?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI